Contineum Therapeutics, Inc. (CTNM) SEC Filings — 2025
12 SEC filings for Contineum Therapeutics, Inc. (CTNM) in 2025.
Filings
- Contineum Therapeutics Files 8-K — 8-K · Dec 15, 2025
- Contineum Therapeutics Files 8-K — 8-K · Dec 11, 2025
- Contineum Therapeutics, Inc. 8-K Filing — 8-K · Nov 20, 2025
- Contineum's Q3 Loss Widens Amid R&D Surge, ATM Offering Boosts Cash — 10-Q · Oct 30, 2025
- Contineum Therapeutics Files 8-K — 8-K · Sep 18, 2025
- Contineum Therapeutics Posts No Revenue, Focuses on R&D — 10-Q · Aug 5, 2025
- Contineum Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Jun 26, 2025
- Contineum Therapeutics Q1 2025: Assets $200M, OpEx $6.7M — 10-Q · May 14, 2025
- Contineum Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 29, 2025
- Contineum Therapeutics Files 8-K — 8-K · Apr 28, 2025
- Contineum Therapeutics: Leadership Changes and New Directors — 8-K · Mar 17, 2025
- Contineum Therapeutics Files 2024 10-K — 10-K · Mar 6, 2025